Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInventory AverageNet MarginOperating MarginReturn on AssetsReturn on Sales

Burning Rock Biotech (BNR) Gross Margin: 2020-2024

Historic Gross Margin for Burning Rock Biotech (BNR) over the last 5 years, with Dec 2024 value amounting to 70.25%.

  • Burning Rock Biotech's Gross Margin rose 381.00% to 75.07% in Q3 2025 from the same period last year, while for Sep 2025 it was 73.12%, marking a year-over-year increase of 439.00%. This contributed to the annual value of 70.25% for FY2024, which is 267.00% up from last year.
  • As of FY2024, Burning Rock Biotech's Gross Margin stood at 70.25%, which was up 3.95% from 67.59% recorded in FY2023.
  • Over the past 5 years, Burning Rock Biotech's Gross Margin peaked at 73.02% during FY2020, and registered a low of 67.47% during FY2022.
  • Moreover, its 3-year median value for Gross Margin was 67.59% (2023), whereas its average is 68.44%.
  • Per our database at Business Quant, Burning Rock Biotech's Gross Margin plummeted by 423bps in 2022 and then skyrocketed by 267bps in 2024.
  • Over the past 5 years, Burning Rock Biotech's Gross Margin (MRY) stood at 73.02% in 2020, then dropped by 2bps to 71.70% in 2021, then dropped by 6bps to 67.47% in 2022, then increased by 0bps to 67.59% in 2023, then increased by 4bps to 70.25% in 2024.
  • Its last three reported values are 70.25% in FY2024, 67.59% for FY2023, and 67.47% during FY2022.